Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Transthyretin (TTR) cardiac amyloidosis.

Ruberg FL, Berk JL.

Circulation. 2012 Sep 4;126(10):1286-300. doi: 10.1161/CIRCULATIONAHA.111.078915. Review. No abstract available.

2.

Fibril in senile systemic amyloidosis is derived from normal transthyretin.

Westermark P, Sletten K, Johansson B, Cornwell GG 3rd.

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2843-5.

3.

Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.

Thenappan T, Fedson S, Rich J, Murks C, Husain A, Pogoriler J, Anderson AS.

Amyloid. 2014 Jun;21(2):120-3. doi: 10.3109/13506129.2013.853660. Epub 2014 Feb 6.

PMID:
24818650
4.

Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations.

Westermark P, Bergström J, Solomon A, Murphy C, Sletten K.

Amyloid. 2003 Aug;10 Suppl 1:48-54.

PMID:
14640042
5.

Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.

Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, Gagliardi C, Milandri A, Rapezzi C, Falk RH.

Circulation. 2014 May 6;129(18):1840-9. doi: 10.1161/CIRCULATIONAHA.113.006242. Epub 2014 Feb 21.

6.

Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.

Connors LH, Doros G, Sam F, Badiee A, Seldin DC, Skinner M.

Amyloid. 2011 Jun;18 Suppl 1:157-9. doi: 10.3109/13506129.2011.574354059. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:159.

PMID:
21838471
7.

Amyloid deposits inside myocardial fibers in transthyretin-Met30 familial amyloidotic polyneuropathy. A histological and biochemical study.

Fiori MG, Salvi F, Plasmati R, Tessari F, Bianchi R, Tassinari CA.

Cardiology. 1994;85(3-4):145-53.

PMID:
7987869
8.

Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.

Hesse A, Altland K, Linke RP, Almeida MR, Saraiva MJ, Steinmetz A, Maisch B.

Br Heart J. 1993 Aug;70(2):111-5. Review.

9.

Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.

Olson LJ, Gertz MA, Edwards WD, Li CY, Pellikka PA, Holmes DR Jr, Tajik AJ, Kyle RA.

N Engl J Med. 1987 Sep 17;317(12):738-42.

PMID:
3627183
10.

Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.

Alhamadsheh MM, Connelly S, Cho A, Reixach N, Powers ET, Pan DW, Wilson IA, Kelly JW, Graef IA.

Sci Transl Med. 2011 Aug 24;3(97):97ra81. doi: 10.1126/scitranslmed.3002473.

11.

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.

Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, Shinriki S, Kawahara S, Jono H, Obayashi K, Ogawa H, Ando Y.

Mod Pathol. 2011 Dec;24(12):1533-44. doi: 10.1038/modpathol.2011.117. Epub 2011 Aug 5.

12.

Spinal multifocal amyloidosis derived from wild-type transthyretin.

Sueyoshi T, Ueda M, Sei A, Misumi Y, Oshima T, Yamashita T, Obayashi K, Shinriki S, Jono H, Shono M, Ando Y, Mizuta H.

Amyloid. 2011 Sep;18(3):165-8. doi: 10.3109/13506129.2011.582197. Epub 2011 Jun 1.

PMID:
21627559
13.

Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.

Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M.

Am Heart J. 2009 Oct;158(4):607-14. doi: 10.1016/j.ahj.2009.08.006.

PMID:
19781421
14.

Transthyretin-related amyloidoses and the heart: a clinical overview.

Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, Ciliberti P, Biagini E, Salvi F, Branzi A.

Nat Rev Cardiol. 2010 Jul;7(7):398-408. doi: 10.1038/nrcardio.2010.67. Epub 2010 May 18. Review.

PMID:
20479782
15.

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Penchala SC, Connelly S, Wang Y, Park MS, Zhao L, Baranczak A, Rappley I, Vogel H, Liedtke M, Witteles RM, Powers ET, Reixach N, Chan WK, Wilson IA, Kelly JW, Graef IA, Alhamadsheh MM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9992-7. doi: 10.1073/pnas.1300761110. Epub 2013 May 28.

16.

A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92).

Saito F, Nakazato M, Akiyama H, Kitahara Y, Date Y, Iwasaki Y, Harasawa S, Hisaki R, Horie T, Kinukawa N, Watanabe T, Sakamaki T, Yagi H, Hoshii Y, Yutani C, Kanmatsuse K.

Hum Pathol. 2001 Feb;32(2):237-9.

PMID:
11230714
17.
18.

Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Jacobson DR, Ittmann M, Buxbaum JN, Wieczorek R, Gorevic PD.

Tex Heart Inst J. 1997;24(1):45-52.

19.

Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.

Bergström J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson BO, Westermark P.

J Pathol. 2005 Jun;206(2):224-32.

PMID:
15810051
20.

Female sex as a possible protective factor from myocardial involvement in transthyretin-related amyloidoses.

Rapezzi C, Perugini E, Salvi F.

Arch Intern Med. 2005 Nov 14;165(20):2429. No abstract available.

PMID:
16287776
Items per page

Supplemental Content

Write to the Help Desk